L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
about
Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammationStriatal molecular signature of subchronic subthalamic nucleus high frequency stimulation in parkinsonian rat.Preclinical assessment of stem cell therapies for neurological diseases.Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian ratNMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and β-arrestin-1 expression in parkinsonian rats.The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian ratEffect of Tianqi antitremor granules on behavioral manifestations and expression of G protein-coupled receptor kinase 6 and β-arrestin1 in levodopa-induced dyskinesia in a rat model of Parkinson's diseaseTherapies for dopaminergic-induced dyskinesias in Parkinson disease.Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.Current Concepts on the Physiopathological Relevance of Dopaminergic ReceptorsAbnormal bidirectional plasticity-like effects in Parkinson's disease.Targeting metabotropic glutamate receptors as a new strategy against levodopa-induced dyskinesia in Parkinson's disease?
P2860
Q27301100-E409A461-1460-42F6-8B72-DD8B58D6AEAFQ34673205-BA331503-DFE2-4321-8CC3-C4F275F7C03FQ34786764-BE9A7BDB-951F-4888-8D2B-AEE05B7E55C1Q35324977-D7E0622F-7443-4236-B53B-A7084B955974Q35815701-0973F505-6B45-4B50-B87C-988C27386DE6Q36738475-054BB4C6-E9E6-422F-B9E3-BC70EDB8120DQ36852272-8D70BCB0-920A-4055-9197-20EF613E5077Q37396700-49532421-9F90-4BD0-8F39-EFCE81E96DF8Q37890986-39DE0C7D-0B07-4005-B802-D382CFC6AEAFQ37973611-AF48FF5F-858C-4D2A-9486-FEFD223DDA62Q39147170-E00EF26F-D32A-46A8-8AE6-5C8A7A29E0DFQ48829642-3F5327DA-1465-4CF3-974A-AA7D2EF99395Q51750611-A56517ED-2956-410E-8045-A80569A81F51
P2860
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
@en
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
@nl
type
label
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
@en
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
@nl
prefLabel
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
@en
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
@nl
P1476
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
@en
P2093
M Angela Cenci
P304
P356
10.1016/S1353-8020(08)70014-2
P478
13 Suppl 3
P577
2007-01-01T00:00:00Z